# Astellas begins construction of R&D and manufacturing facilities in Japan and US

Astellas Pharma Inc. announced the start of construction of new research, development and manufacturing facilities for drugs using innovative modalities including antibodies and cell therapies in Toyama and Tsukuba, Japan, and Massachusetts, United States.

- Type: New facility
- Announced: 2018-10-31
- Where: Toyama and Tsukuba, Japan; Massachusetts, United States, Japan
- Status: under construction
- Products: antibodies, cell therapies, gene therapies, vaccines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Astellas Pharma Inc.](https://endata.com/companies/35227.md)

## Sources

- [stage.mediaroom.com](https://stage.mediaroom.com/globalastellas/2018-10-31-Astellas-Announces-Construction-of-New-Research,-Development-and-Manufacturing-Facilities-for-Drugs-Using-Innovative-Modalities-Technologies-Including-Antibodies-and-Cell-Therapies), 2018-10-31: "Astellas is focused on creating innovative healthcare solutions for patients with high unmet medical needs through unique combinations of Biology and Modality/Technology based on emerging science."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.